ASV Therapy for Insomnia: Can Adaptive Servo Ventilation Help Sleep Loss?
Official title: Evaluation of Adaptive Servo Ventilation Therapy for Insomnia Treatment Among Patients With Primary Insomnia
Run by ResMed · NCT07011966 · Data updated 2026-11-12
This study tests whether adaptive servo ventilation can lessen insomnia symptoms in adults with moderate to severe chronic insomnia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | ResMed Industry-sponsored |
| Locations | 1 site (Detroit, Michigan) |
| Status | Recruiting |
| Started | March 1, 2026 |
| Main results expected | December 2026 |
| Study ends | February 2027 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT07011966 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older with moderate to severe insomnia (ISI ≥ 15) diagnosed as Insomnia Disorder, who are naïve to sleep-disordered breathing treatments and can use a smartphone app for data syncing.
✕Probably not a fit
Patients with primary sleep-disordered breathing issues, other severe sleep disorders, or high-risk respiratory conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective study to assess the effect of adaptive servo ventilation therapy on insomnia severity in adults with primary insomnia. Participants must have moderate to severe insomnia (ISI ≥ 15) and be naïve to sleep-disordered breathing treatments. Intervention consists of ASV therapy, with data syncing via a smartphone app for HSAT data. The study targets adults who can provide informed consent in English and own a smartphone. Outcomes will focus on changes in insomnia severity and related sleep metrics over the course of treatment.
Why it matters
Potential benefit: If successful, ASV therapy could reduce insomnia symptoms and improve sleep quality for patients with moderate to severe insomnia.
How similar studies have gone: Previous research in related sleep disorders suggests potential benefits of ventilation strategies, but application to primary insomnia is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years old * Complaint of insomnia when presenting at clinic * Diagnosis of moderate to severe insomnia through the Insomnia Severity Index (ISI) with a score ≥ 15 * Meet diagnostic criteria of Insomnia Disorder (per American Academy of Sleep Medicine) * Naïve to treatment for sleep-disordered breathing (SDB), including CPAP, APAP, ASV; mandibular repositioning devices (MRDs), and any other nasal or oral therapy with a primary indication of treating SDB * Owns a smartphone and is able to install an application for HSAT data syncing. * Able to fully understand study information in English and sign informed consent Exclusion Criteria: * Primary complaint of sleep-disordered breathing or issues with apneas during sleep or excessive daytime sleepiness * Pregnant or planning to be pregnant * Any prior diagnosis of severe respiratory disorder or severe sleep disorder such as restless leg syndrome (RLS), idiopathic hypersomnia, or narcolepsy * High risk for moderate to severe OSA based on STOP-BANG score. * BMI \> 40 kg/m2 * Anticipated changes to start or stop sedative or psychotropic medications during the course of the trial. * Medical history of congestive heart failure (CHF) or other potentially unstable cardiac disease as well as chronic lung diseases or other debilitating medical conditions that manifest as more prominent in the patient's health compared to their sleep complaints. * Daily use of opiate medications * Known contraindications to PAP therapy as listed in the indication for use (i.e. heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤45%) and moderate to severe predominant central sleep apnea). * Inability to pre-emptively comply with study procedures * Patients who wish to continue using sleeping pills/hypnotics during the study * Patients with conditions affecting the rotation of the condyle in the temporo-mandibular joint.
Where it's running
-
C.S. Mott Center
Detroit, Michigan, United States Recruiting
Study contacts
- Study coordinator: Daniela Tellez, MPH
- Email: daniela.tellez@resmed.com
- Phone: 858 264 9263
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SleepCogni for children with chronic insomnia
A handheld SleepCogni device is tested to see if it helps kids aged 6–16 with chronic insomnia sleep better.
-
Music therapy after stroke
This trial tests whether adding music therapy to standard care helps stroke patients sleep better and feel less anxious or depressed while in the hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Nurse-guided app-based brief behavioral therapy for insomnia in older adults
Aging adults with insomnia will be asked to try a nurse-supported, smartphone app therapy for four weeks to see if it helps with sleep.
-
Three rTMS approaches to lessen insomnia-related pain after exercise-induced muscle soreness
This study tests whether three different rTMS approaches can reduce pain sensitivity and improve recovery in adults with insomnia after inducing muscle soreness from exercise.
-
Insomnia and Sleep Disruption's Effect on Pain Sensitivity and Muscle Soreness After Exercise
This study tests whether poor sleep or insomnia affects how people feel pain and recover from exercise-induced muscle soreness in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.